Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | EBF | EROK |
|---|---|---|
| Price | $22.50 | $21.65 |
| Change today | ▼ 0.27% | ▼ 0.55% |
| Market cap | $569.65M | $570.59M |
| Return, 3 months | +7.3% | -0.2% |
| Return, year to date | +29.7% | – |
| Return, 1 year | +34.1% | – |
| P/E (TTM) | 14.7 | 8.2 |
| P/B | 1.8 | 1.7 |
| P/E percentile vs own 5y | 75th | 14th |
| Dividend yield | 4.44% | – |
| Revenue growth (YoY, latest qtr) | +3.4% | +74.0% |
| Net profit growth (YoY) | -28.6% | +43.8% |
| Gross margin | 30.6% | 51.9% |
| Operating margin | 13.6% | -28.4% |
| Net margin | 9.8% | 37.0% |
| Return on equity | 12.6% | 19.7% |
| Analyst target vs. price | – | +35.1% |
| Analyst buy share | – | 75% |
| RSI (14) | 67 | 39 |
| 30-day volatility | 11.7% | 35.4% |
| Max drawdown, 1 year | -10.6% | -23.8% |
| Trend read | Strong uptrend | Strong downtrend |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
